69448-016-11 : NDC 2026 Code

69448-016-11 : Trastuzumab-strf ( Hercessi )

Additionally :

You can get information about “69448-016-11” NDC code in 69448-016-11 in HTML format

HTML | 69448-016-11 in TXT (Plain Text) format

TXT | 69448-016-11 in PDF (Portable Document Format)

PDF | 69448-016-11 in XML format

XML formats.

NDC Code : 69448-016-11 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "69448-016-11",
    "PackageDescription": "1 VIAL, MULTI-DOSE in 1 CARTON (69448-016-11)  / 20 mL in 1 VIAL, MULTI-DOSE",
    "NDC11Code": "69448-0016-11",
    "ProductNDC": "69448-016",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Hercessi",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Trastuzumab-strf",
    "DosageFormName": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
    "RouteName": "INTRAVENOUS",
    "StartMarketingDate": "20250101",
    "EndMarketingDate": null,
    "MarketingCategoryName": "BLA",
    "ApplicationNumber": "BLA761346",
    "LabelerName": "Accord BioPharma Inc.",
    "SubstanceName": "TRASTUZUMAB-STRF",
    "StrengthNumber": "420",
    "StrengthUnit": "mg/20mL",
    "Pharm_Classes": "HER2/Neu/cerbB2 Antagonists [MoA], HER2/neu Receptor Antagonist [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-01-08",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20250101",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}